✦ LIBER ✦

Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young

✍ Scribed by Vilma Mantovani; Silvana Salardi; Vincenzo Cerreta; Daniela Bastia; Marinella Cenci; Luca Ragni; Stefano Zucchini; Raffaele Parente; Alessandro Cicognani

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 35 KB
Volume: 22
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.9179

No coin nor oath required. For personal study only.

✦ Synopsis

Maturity

-onset diabetes of the young (MODY) is a clinically heterogeneous group of disorders characterized by early onset non-insulin-dependent diabetes mellitus, autosomal dominant inheritance, and primary defect in the function of the beta cells of the pancreas. Mutations in the glucokinase (GCK) gene account for 8%-56% of MODY, with the highest prevalences being found in the southern Europe. While screening for GCK mutations in 28 MODY families of Italian origin, we identified 17 different mutations (corresponding to 61% prevalence), including eight previously undescribed ones. The novel sequence variants included five missense mutations (p.Lys161Asn c.483G>C in exon 4, p.Phe171Leu c.511T>C in exon 5 and p.Thr228Ala c.682A>G, p.Thr228Arg c.683C>G, p.Gly258Cys c.772G>T in exon 7), one nonsense mutation (p.Ser383Ter c.1148C>A in exon 9), the splice site variant c.1253+1G>T in intron 9, and the deletion of 12 nucleotides in exon 10 (p.Ser433_Ile436del c.1298_1309del12). Our study indicates that mutations in the GCK/MODY2 gene are a very common cause of MODY in the Italian population and broadens our knowledge of the naturally occurring GCK mutation repertoire.

📜 SIMILAR VOLUMES

Identification of 21 novel glucokinase (

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY)

✍ K.L. Thomson; A.L. Gloyn; K. Colclough; M. Batten; L.I.S. Allen; F. Beards; A.T. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 1 views

## Maturity -onset diabetes of the young (MODY) resulting from mutations in the glucokinase (GCK) gene accounts for approximately 20% of MODY in the UK. W e have performed fluorescent single stranded conformation polymorphism (F-SSCP) analysis or direct sequencing of the GCK gene in 212 patients re

Three novel missense mutations in the gl

Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY)

✍ Barbara Guazzini; Davide Gaffi; Davide Mainieri; Giuseppe Multari; Renzo Cordera 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB

The maturity-onset diabetes of the young (MODY), an autosomal dominant form of non-insulin dependent diabetes mellitus (NIDDM), is caused by mutations in the glucokinase (GK, MODY 2) and in the hepatocyte nuclear factor 1 (MODY 3) and 4 (MODY1) genes. We have screened the glucokinase gene by the pol

Glucokinase (GCK) mutations in hyper- an

Glucokinase (GCK) mutations in hyper- and hypoglycemia: Maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy

✍ Anna L. Gloyn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

## Communicated by Mark H. Paalman Glucokinase is a key regulatory enzyme in the pancreatic beta-cell. It plays a crucial role in the regulation of insulin secretion and has been termed the pancreatic beta-cell sensor. Given its central role in the regulation of insulin release, it is understandab

Update on mutations in glucokinase (GCK)

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia

✍ Kara K. Osbak; Kevin Colclough; Cecile Saint-Martin; Nicola L. Beer; Christine B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 1 views

Glucokinase is a key regulatory enzyme in the pancreatic beta-cell. It plays a crucial role in the regulation of insulin secretion and has been termed the glucose sensor in pancreatic beta-cells. Given its central role in the regulation of insulin release it is understandable that mutations in the g

Identification of novel GCK and HNF1A/TC

Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY)

✍ Dalia Toaima; Andrea Näke; Jutta Wendenburg; Kirsten Praedicow; Julia Rohayem; K 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

Maturity-onset diabetes of the young is a genetically heterogenous autosomal dominant form of diabetes mellitus, characterized by an early age at onset and a primary defect in beta-cell function. Forty families with a clinical presentation suggestive of MODY were screened for the most common MODY su

GCK and HNF1A mutations in Canadian fami

GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY)

✍ Henian Cao; Sanam Shorey; John Robinson; Daniel L. Metzger; Laura Stewart; Eliza 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB 👁 1 views

Maturity onset diabetes of the young (MODY) is a genetically heterogeneous form of type 2 diabetes that is characterized by autosomal dominant inheritance, onset in early adulthood and a primary defect in insulin secretion. Mutations in at least six genes have been shown to underlie MODY, including